☆ 4.7 Article

Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Immuno-Modulatory Effects of Dexamethasone in Severe COVID-19-A Swedish Cohort Study

Sana Asif et al.

Summary: Dexamethasone has been shown to decrease mortality in severe COVID-19 patients and is associated with altered immunological and physiologic responses. Patients treated with Dexamethasone had higher blood glucose but lower blood lactate, plasma cortisol, immunoglobulins, D-dimer, cytokines, syndecan-1, and E-selectin levels, and received less organ support. Early administration of Dexamethasone within 14 days of COVID-19 debut reduced the mortality risk by 40%.

BIOMEDICINES (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Corticosteroids for COVID-19: worth it or not?

Fariya Akter et al.

Summary: The use of corticosteroids in COVID-19 patients has sparked controversy and requires further in-depth research to evaluate both its effectiveness and potential side effects.

MOLECULAR BIOLOGY REPORTS (2022)

Add to Collection

Article Medicine, General & Internal

Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs

Taejoon Won et al.

Summary: The article explains the copyright ownership and the license agreement it follows.

EBIOMEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Inflammation-Induced Coagulopathy Substantially Differs Between COVID-19 and Septic Shock: A Prospective Observational Study

Melanie Dechamps et al.

Summary: The study compared the clinical characteristics and inflammation response between patients with septic shock and critical COVID-19, and found significant differences in the inflammatory reaction and coagulopathy between the two conditions. Critical COVID-19 exhibited a distinct inflammatory response involving IL-1 beta and T lymphocyte activation, while septic shock displayed higher levels of IL-6 and IL-8 as well as enhanced myeloid response. The coagulopathy of COVID-19 also differed from sepsis-induced coagulopathy, suggesting the need to evaluate modulating tissue factor release and activity in the treatment of critical COVID-19.

FRONTIERS IN MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients

Virginie Montiel et al.

Summary: SARS-CoV-2 infection can cause increased oxidative stress and decreased nitric oxide bioavailability in ICU COVID-19 patients, which may contribute to endothelial dysfunction. Nitric oxide bioavailability is correlated with oxygenation parameters in hospitalized COVID-19 patients.

EBIOMEDICINE (2022)

Add to Collection

Article Microbiology

Early Corticosteroid Therapy May Increase Ventilator-Associated Lower Respiratory Tract Infection in Critically Ill Patients with COVID-19: A Multicenter Retrospective Cohort Study

Jean-Baptiste Mesland et al.

Summary: In a multicenter retrospective cohort study of critically ill COVID-19 patients undergoing invasive mechanical ventilation, early corticosteroid therapy was independently associated with ventilator-associated lower respiratory tract infection (VA-LRTI).

MICROORGANISMS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study

Laure Morimont et al.

Summary: This study evaluated biomarkers of NETs' formation in ICU patients with infections and found that H3.1 and Cit-H3R8 nucleosomes are interesting markers of global cell death and neutrophil activation. Nu.H3.1 allows evaluation of disease severity and differs between septic shock and critical COVID-19 patients.

BIOMOLECULES (2022)

Add to Collection

Letter Respiratory System

Association between dexamethasone treatment and the host response in COVID-19 patients admitted to the general ward

Justin de Brabander et al.

Summary: This study investigated the mechanisms of dexamethasone in COVID-19 patients and found that dexamethasone can reduce plasma levels of interleukin-6 and interleukin-1 receptor antagonist, without affecting other inflammation parameters.

RESPIRATORY RESEARCH (2022)

Add to Collection

Review Medicine, General & Internal

Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019

Pankaj Bansal et al.

Summary: Hydroxychloroquine, initially an antimalarial, is now used for autoimmune diseases, but its efficacy in COVID-19 lacks sufficient evidence. Its mechanisms are related to inhibiting immune responses and lysosomal functions, but may also lead to heart issues.

ANNALS OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics

Wang-Da Liu et al.

Summary: In this case report, six patients with mild to moderate COVID-19 were treated with hydroxychloroquine for 14 days, showing no complications. However, prolonged virus shedding was still observed despite treatment with HCQ, and the impact on cytokine kinetics remained unclear.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2021)

Add to Collection

Review Critical Care Medicine

A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy

Julie Goswami et al.

Summary: COVID-19 is associated with significant coagulopathy, leading to increased rates of venous and arterial thromboembolic events. Inflammatory response in COVID-19 is linked to coagulopathy, posing challenges for diagnosis, prevention, and treatment of thrombotic complications. Endothelial injury and augmented innate immune response play a role in the development of thrombosis in COVID-19.

SHOCK (2021)

Add to Collection

Article Medicine, General & Internal

Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19 The HEP-COVID Randomized Clinical Trial

Alex C. Spyropoulos et al.

Summary: Therapeutic-dose low-molecular-weight heparin reduces major thromboembolism and death in high-risk inpatients with COVID-19, with no significant effect observed in critically ill patients.

JAMA INTERNAL MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit The INSPIRATION Randomized Clinical Trial

Parham Sadeghipour et al.

Summary: This study compared the effect of intermediate-dose and standard prophylactic anticoagulation on a composite outcome among COVID-19 patients admitted to the ICU. The results showed no significant difference between the two groups in terms of thrombotic events, ECMO therapy, or mortality within 30 days. The study does not recommend routine use of intermediate-dose prophylactic anticoagulation in unselected ICU patients with COVID-19.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Review Infectious Diseases

Associations of immunological features with COVID-19 severity: a systematic review and meta-analysis

Zhicheng Zhang et al.

Summary: Our meta-analysis showed significantly lower levels of immune cells (CD3(+) T, CD4(+) T, CD8(+) T, B and NK cells), higher levels of cytokines (TNF-alpha, IL-5, IL-6 and IL-10) and higher levels of chemokines (MCP-1, IP-10 and eotaxin) in severe cases compared to mild cases of COVID-19. These immunological features could be useful for assessing disease severity and triaging COVID-19 patients effectively.

BMC INFECTIOUS DISEASES (2021)

Add to Collection

Article Medicine, General & Internal

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

Patrick R. Lawler et al.

Summary: This study showed that therapeutic-dose anticoagulation with heparin in non-critically ill patients with Covid-19 increased the likelihood of survival to hospital discharge and reduced the need for cardiovascular or respiratory organ support compared to usual-care thromboprophylaxis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

Ewan C. Goligher et al.

Summary: In critically ill patients with Covid-19, initial therapeutic-dose anticoagulation did not result in improved survival rates or fewer days requiring cardiovascular or respiratory organ support compared to usual-care pharmacologic thromboprophylaxis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Immunology

Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19

Aldo Bonaventura et al.

Summary: The authors suggest that SARS-CoV-2 infection induces a prothrombotic state and dysregulated immunothrombosis, leading to severe manifestations of COVID-19. They also discuss potential antithrombotic and immunomodulating drugs for treating COVID-19 patients, aiming to reduce the acute and long-term consequences of the disease by targeting immunothrombosis.

NATURE REVIEWS IMMUNOLOGY (2021)

Add to Collection

Review Hematology

Venous Thromboembolism, Corticosteroids and COVID-19: A Systematic Review and Meta-Analysis

Azza Sarfraz et al.

Summary: COVID-19 patients treated with corticosteroids are at higher risk of developing VTE, emphasizing the importance of individual risk assessment to reduce VTE incidence and improve clinical outcomes.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2021)

Add to Collection

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Add to Collection

Article Medicine, General & Internal

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

Dominic Wichmann et al.

ANNALS OF INTERNAL MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis

Zhikang Ye et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2020)

Add to Collection

Article Critical Care Medicine

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

Julie Helms et al.

INTENSIVE CARE MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Systemic Inflammatory Response Syndrome Is a Major Contributor to COVID-19-Associated Coagulopathy Insights From a Prospective, Single-Center Cohort Study

Paul Masi et al.

CIRCULATION (2020)

Add to Collection

Article Pharmacology & Pharmacy

Pharmaco-Immunomodulatory Therapy in COVID-19

John G. Rizk et al.

DRUGS (2020)

Add to Collection

Article Hematology

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

F. A. Klok et al.

THROMBOSIS RESEARCH (2020)

Add to Collection

Article Medicine, General & Internal

Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19 The CoDEX Randomized Clinical Trial

Bruno M. Tomazini et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Medicine, General & Internal

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial

Derek C. Angus et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Medicine, General & Internal

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis

Jonathan A. C. Sterne et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Review Medicine, General & Internal

Cytokine Storm

David C. Fajgenbaum et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Critical Care Medicine

Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes

Judith van Paassen et al.

CRITICAL CARE (2020)

Add to Collection

Review Medicine, General & Internal

Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis

Mahmoud B. Malas et al.

ECLINICALMEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey

Toshiaki Iba et al.

BMJ OPEN (2017)

Add to Collection

Article Rheumatology

Infection Risk and Safety of Corticosteroid Use

Jameel Youssef et al.

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2016)

Add to Collection

Review Immunology

Thrombosis as an intravascular effector of innate immunity

Bernd Engelmann et al.

NATURE REVIEWS IMMUNOLOGY (2013)

Add to Collection

Review Cell Biology

The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights

Agnes E. Coutinho et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)

Add to Collection

Article Cell Biology

Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps

Venizelos Papayannopoulos et al.

JOURNAL OF CELL BIOLOGY (2010)

Add to Collection

Article Multidisciplinary Sciences

Extracellular DNA traps promote thrombosis

Tobias A. Fuchs et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Add to Collection

Article Critical Care Medicine

The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation

Alan E. Jones et al.

CRITICAL CARE MEDICINE (2009)

Add to Collection

Article Immunology

T cell responses to whole SARS coronavirus in humans

Chris Ka-fai Li et al.

JOURNAL OF IMMUNOLOGY (2008)

Add to Collection

Article Immunology

Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia

Martijn D. de Kruif et al.

JOURNAL OF IMMUNOLOGY (2007)

Add to Collection

Review Pharmacology & Pharmacy

How corticosteroids control inflammation: Quintiles prize lecture 2005

Peter J. Barnes

BRITISH JOURNAL OF PHARMACOLOGY (2006)

Add to Collection

Article Multidisciplinary Sciences

Neutrophil extracellular traps kill bacteria

V Brinkmann et al.

SCIENCE (2004)

Add to Collection

Article Hematology

Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation - On behalf of the Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH)

FB Taylor et al.

THROMBOSIS AND HAEMOSTASIS (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.